Key result
Higher serum adiponectin is linked to lower arteriosclerosis severity in IgA nephropathy.
Why the study?
The relationship between serum high-molecular-weight or total adiponectin levels and arteriosclerosis in patients with IgA nephropathy had not been reported.
Are serum high-molecular-weight and total adiponectin levels associated with the severity of arteriosclerosis in patients with IgA nephropathy?
Cross-Sectional (n=72)
No
Are serum high-molecular-weight and total adiponectin levels associated with the severity of arteriosclerosis in patients with IgA nephropathy?
Effect estimate: st beta -0.218
p-value: p=0.026
Serum total adiponectin levels are independently and inversely associated with the severity of renal arteriosclerosis in patients with IgA nephropathy, with HMW adiponectin showing a stronger correlation in males.
May link lower HMW adiponectin to arteriosclerosis in IgA nephropathy with preserved GFR; leaves open whether measurement refines risk assessment or warrants prospective trials.
BACKGROUND/AIM: Adiponectin has attracted a great deal of attention because of its antiatherogenic properties. Previous studies have reported that high-molecular-weight (HMW) adiponectin may be the active form of this protein, but there have been no reports on the relationship between serum adiponectin and arteriosclerosis. The aim of our study was to determine whether HMW or total adiponectin levels are associated with arteriosclerosis in patients with IgA nephropathy. METHODS: We enrolled 72 patients aged 34.3 +/- 12.7 years, from whom interlobular arteries were obtained by renal biopsy in our hospital between 2003 and 2006 and who were confirmed to have IgA nephropathy. We assessed them in relation to age, gender, body mass index, presence of hypertension, serum total cholesterol, triglyceride, uric acid, high-sensitive C-reactive protein and HMW adiponectin and total adiponectin levels, creatinine clearance, and urinary protein excretion. The severity of arteriosclerosis was semiquantitatively evaluated and classified into the following four grades: 0 = none; 1 = mild; 2 = moderate, and 3 = severe. RESULTS: Multiple stepwise regression analysis showed associations between arteriosclerosis grade and age [standard regression coefficient (st beta) = 0.560, p < 0.001], total adiponectin (st beta = -0.218, p = 0.026), triglyceride (st beta = 0.222, p = 0.033), and presence of hypertension (yes = 1, no = 0; st beta = 0.182, p = 0.036) in the IgA nephropathy patients as a whole and associations between arteriosclerosis grade and age (st beta = 0.708, p < 0.001), HMW adiponectin (st beta = -0.321, p = 0.035), and triglyceride (st beta = 0.292, p = 0.038) in the male IgA nephropathy patients. CONCLUSIONS: Serum total adiponectin levels are an independent determinant of arteriosclerosis in IgA nephropathy patients. It was noteworthy that in males the serum HMW adiponectin levels correlated more strongly with arteriosclerosis grade than the total adiponectin levels did. Adiponectin may prevent renal arteriosclerosis.
No takes yet. Share an insight, caveat, or question.
Iwasa et al. (2008) conducted a cross-sectional in IgA nephropathy (n=72). Serum high-molecular-weight and total adiponectin was evaluated on Arteriosclerosis grade (st beta -0.218, p=0.026). Serum total adiponectin levels were independently associated with lower arteriosclerosis grade in patients with IgA nephropathy (standard regression coefficient -0.218, p=0.026).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: